Arthritis: JAMA Blasts Vioxx Ghostwriters, Guest Authors, and Mortality Reporting
Pediatric rheumatologists gained a new tool for use in treating juvenile idiopathic arthritis (JIA) with the US Food and Drug Administration's approval of Orencia (abatacept)....
Arthritis: Orencia Gets FDA Okay for JIA
Pediatric rheumatologists gained a new tool for use in treating juvenile idiopathic arthritis (JIA) with the US Food and Drug Administration's approval of Orencia (abatacept)....
Bones: Twin Spine Study Shows Genes, Not Injuries Cause Most Disc Problems
Researchers with the Twin Spine Study show that most degenerative back problems are linked to genes, not to aging, injuries, lifting, or driving. They also identified several genes involved....
Pain: Pain-Fatigue Link May Explain Why FM, CFS Are More Prevalent in Women
A biological link between pain and fatigue may help explain why more women than men are diagnosed with chronic pain and fatigue conditions like fibromyalgia and chronic fatigue syndrome...
Consumer News: Novartis Says Aclasta Better at Boosting Bone Mass
Novartis reported study results indicating a once-yearly infusion of Aclasta is more effective than risedronate at increasing bone mass in patients taking steroids...
New from PubMed: Granuloma Annulare Induced by Antitumor Necrosis Factor Therapy
Researchers found evidence of a link between TNF inhibition and the development of granuloma annulare skin lesions in some patients...
|